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ABSTRACT 
The brain shows greater plasticity in early life than in maturity, which paradoxically 
renders the organ more vulnerable to hypoxia-ischemia (HI)- and cranial irradiation (IR)-
induced damage. Apoptosis after a HI insult is more pronounced in the immature vs. mature 
brain and develops over time; hence, blockade of the apoptotic cascade provides a target for 
delayed neuroprotective interventions aimed at reducing HI-provoked brain damage. 
Moreover, inflammation subsequent to the initial insult exacerbates HI-induced brain 
damage, and is also a target for interventions. Meanwhile, the profound progressive 
decrease in neurogenesis after IR is associated with the deleterious effects of chronic 
inflammation. The overall goal of this thesis was to investigate potential neuroprotective 
strategies to decrease brain injury through the regulation of apoptosis and inflammation. 
First, the impact of a cell-penetrating, Bax-inhibiting peptide (BIP) was assessed in a 
neonatal mouse model of HI. BIP administration moderated injury to the gray and white 
matter, and ameliorated sensorimotor and cognitive deficits. These actions were attributed 
to diminished Bax activation and decreased mitochondrial release of the pro-apoptotic 
proteins, cytochrome c and apoptosis-inducing factor (AIF). Next, the influence of delayed 
and extended systemic administration of a caspase inhibitor, Q-VD-OPh, was examined in 
neonatal HI. Consequently, Q-VD-OPh decreased the expression of pro-inflammatory 
chemokines, reduced signs of brain injury, and transiently overturned HI-induced 
sensorimotor deficits and hyperactivity. The present findings also revealed a novel 
mechanism amenable for therapeutic strategies after neural progenitor cell (NPC) 
transplantation into the brain, and showed that active cell death of NPCs plays a key role in 
the release of heat-stable, neuroprotective proteins. Specifically, conditioned medium (CM) 
originating from dying NPCs safeguarded hippocampal neurons against glutamate toxicity 
and trophic factor withdrawal in vitro, and exerted protective actions against ischemic brain 
damage in vivo. Finally, the current data demonstrated that peripheral macrophages do not 
contribute to the inflammatory response in the hippocampus after IR. Moreover, the 
microglial response was more pronounced and protracted in the juvenile vs. adult brain, and 
the inflammatory response appeared to be chronic, lasting at least 1 month after IR. Taken 
together, the observations presented herein provide insight into the control of apoptosis and 
inflammation after ischemic or IR injury to the developing brain. 
LIST OF SCIENTIFIC PAPERS 
This thesis is based on the following manuscripts, which are referred to in this document by 
their corresponding Roman numerals. 	  
I. Xiaoyang Wang
*, Wei Han*, Xiaonan Du, Changlian Zhu, Ylva Carlsson, 
Carina Mallard, Etienne Jacotot, and Henrik Hagberg (2010). 
Neuroprotective effect of Bax-inhibiting peptide on neonatal brain injury. 
Stroke 41, 2050–2055. 
II. Wei Han, Yanyan Sun, Xiaoyang Wang, Changlian Zhu
#, and Klas 
Blomgren# (2014). Delayed, long-term administration of the caspase 
inhibitor Q-VD-OPh reduced brain injury induced by neonatal hypoxia-
ischemia. Dev Neurosci 36, 64–72. 
III. Eva-Maria Meißner
*, Wei Han*, Stefanie Neunteibl, Jörg Kahnt, Amalia 
Dolga, Cuicui Xie, Changlian Zhu, Klas Blomgren#, and Carsten Culmsee#. 
Phoenix rising: Neural progenitor cell death confers neuroprotection. 
Manuscript. 
IV. Wei Han, Takashi Umekawa, Kai Zhou, Changlian Zhu
#, and Klas 
Blomgren#. Blood-derived macrophages do not contribute to the 
inflammatory response after cranial irradiation in either the juvenile or the 
adult brain. Submitted.  
	  
	  
Publications not included in this thesis: 
 Han W., Song J., Liu A., Huo K., Xu F., Cui S., Wang X. and Zhu C. 
(2011). "Trends in live births in the past 20 years in Zhengzhou, China." 
Acta Obstet Gynecol Scand 90(4): 332-337. 
 Hellgren G.,* Han W.,* Wang X., Lofqvist C., Hagberg H., Mallard C. and 
Hellstrom A. (2011). "Safety aspects of longitudinal administration of IGF-
I/IGFBP-3 complex in neonatal mice." Growth Horm IGF Res 21(4): 205-
211. 
 Wang X., Leverin A. L., Han W., Zhu C., Johansson B. R., Jacotot E., Ten 
V. S., Sims N. R. and Hagberg H. (2011). "Isolation of brain mitochondria 
from neonatal mice." J Neurochem 119(6): 1253-1261. 
	  
*Both authors contributed equally to this article. 
# Shared senior authorship. 
  
	  
	  
TABLE OF CONTENTS  
1 Introduction ....................................................................................................................... 1 
1.1 Clinical background ...................................................................................................... 1 
1.2 HIE ................................................................................................................................ 2 
1.2.1 Apoptosis .............................................................................................................. 2 
1.2.1.1 The BCL2 family ............................................................................................ 3 
1.2.1.2 Caspases .......................................................................................................... 4 
1.2.2 Inflammatory response ......................................................................................... 5 
1.2.2.1 Microglia ........................................................................................................ 6 
1.2.2.2 Cytokines and Chemokines ............................................................................ 7 
1.2.3 Excitotoxicity ........................................................................................................ 8 
1.2.4 Oxidative stress ..................................................................................................... 9 
1.2.5 Neuroprotective strategies .................................................................................... 9 
1.3 IR-induced brain injury .............................................................................................. 11 
1.3.1 Hippocampal neurogenesis ................................................................................. 11 
1.3.2 IR-induced neuroinflammation ........................................................................... 13 
2 Aims of the thesis ............................................................................................................. 15 
3 Methods ............................................................................................................................ 16 
3.1 Animals (I-IV) ............................................................................................................ 16 
3.2 HI model (I-III) ........................................................................................................... 16 
3.3 IR model (IV) ............................................................................................................. 17 
3.4 Cell culture and preparation of conditioned medium (CM, III) ................................. 17 
3.5 Behavioral evaluation (I and II) .................................................................................. 18 
3.6 Immunohistochemistry (I-IV) ..................................................................................... 19 
4 Results and discussion ..................................................................................................... 20 
4.1 Bax inhibiting peptide (BIP) reduces neonatal HI brain injury (I) ............................. 20 
4.2 Role of caspases in apoptosis and inflammation after neonatal HI-induced brain 
injury (II) .......................................................................................................................... 22 
4.3 Neural stem cell-based interventions for neonatal HI-induced brain injury (III) ....... 25 
4.4 Involvement of monocyte-derived macrophages in the inflammatory response after 
IR (IV) .............................................................................................................................. 28 
5 Clinical implications and future perspectives ............................................................... 30 
6 Acknowledgements .......................................................................................................... 33 
7 References ......................................................................................................................... 35 
	  
	  
LIST OF ABBREVIATIONS 
AIF Apoptosis-inducing factor 
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
Apaf-1 Apoptotic protease activating factor 1 
Bax Bcl-2-associated X protein 
Bak Bcl-2 homologous antagonist killer 
BBB Blood brain barrier 
Bcl-2 B-cell lymphoma 2 
Bcl-xL B-cell lymphoma-extra large 
Bid BH3 interacting-domain death agonist 
BIP Bax inhibiting peptide 
CA Cornu ammonis 
Caspase Cysteine-aspartic proteases 
CCL2 Chemokine (C-C motif) ligand 2 
CCL3 Chemokine (C-C motif) ligand 3 
CCR2 C-C chemokine receptor type 2 
CM Conditioned medium 
CNS Central nervous system 
CS Conditional stimulus 
CX3CR1 CX3C chemokine receptor 1 
Cytc Cytochrome c 
DAB 3,3' Diaminobenzidine 
dATP Deoxyadenosine triphosphate 
DISC Death-inducing signaling complex 
DG Dentate gyrus 
GABA γ-Aminobutyric acid 
GCL Granular cell layer 
GFP Green fluorescent protein 
HIE Hypoxic-ischemic encephalopathy 
IL-1β Interleukin 1β 
IL-18 Interleukin 18 
IR Irradiation 
KA Kainic acid 
MCP-1 Monocyte chemotactic protein 1 
	   	  
	  
	  
MEF Mouse embryonic fibroblast 
MOMP Mitochondrial outer membrane permeabilization 
MPT Mitochondrial permeability transition 
NMDA N-methyl-D-aspartate 
NO Nitric oxide 
NPC Neural progenitor cell 
PBS Phosphate-buffered saline 
PFA Paraformaldehyde 
PND Postnatal day 
Q-VD-OPh Quinoline-Val-Asp(OMe)-CH2-PH 
RFP Red fluorescent protein 
RNOS Reactive nitrogen oxide species 
ROS Reactive oxygen species 
RT Room temperature 
SGZ Subgranular zone 
SVZ Subventricle zone 
TBS Tris-buffered saline 
TNF-α Tumor necrosis factor α 
US Unconditional stimulus 
	  
  
	  
	  
  
1	  
	  
1 Introduction 
1.1 Clinical background 
Infants in the neonatal period, or the first 28 days of life, have the highest childhood 
mortality rate, accounting for 44 % of all deaths in children under 5 years of age (UNICEF 
2014). Perinatal asphyxia, a severe condition characterized by impaired respiratory gas 
exchange, is a leading cause of neonatal death (23 %) (Liu, Johnson et al. 2012). However, 
thanks to advances in perinatal care over the past two decades (including improvements in 
safe childbirth procedures and more effective care of newborns), the neonatal death rate has 
significantly declined (Lawn, Kinney et al. 2012). Perinatal asphyxia is often followed by 
dysfunction of one or more organs or organ systems, typically the central nervous system 
(CNS) because of its high demand for oxygen and blood flow (Martin-Ancel, Garcia-Alix 
et al. 1995). Perinatal hypoxic-ischemic encephalopathy (HIE) is a common form of brain 
damage triggered by asphyxia, manifests itself by difficulty in initiating and maintaining 
respiration, and also by depression of tone and reflexes, subnormal consciousness, and 
frequently, by seizures. HIE is a serious disorder with critical neuropsychological sequelae 
among survivors. Available estimates suggest that all survivors of severe HIE show 
neurological deficits at one time or another, whereas in moderate HIE, the number is ~30–
40 % (Robertson, Finer et al. 1989; Dixon, Badawi et al. 2002). 
Although only ~7 % of reported brain and CNS tumors occur in children aged 0–19 years 
(Dolecek, Propp et al. 2012), brain tumors are the second most common type of cancer 
(after leukemia) in children, and the most common type of solid tumor. In fact, brain 
tumors are responsible for an estimated 17 % of all childhood cancers (Howlader, Noone et 
al. 2015). The 5-year survival rate for children with brain tumors has dramatically increased 
due to treatment advances (Armstrong, Stovall et al. 2010; Hellings, Peeters et al. 2010). 
Treatment modalities vary according to the affected cell type, tumor grade, and location in 
the brain, but mainly consist of surgery, radiation therapy, and chemotherapy. 
Unfortunately, these effective treatments are associated with late-onset adverse events (e.g., 
endocrine disorders, cognitive deficits, and developmental impairments occurring months 
or years after treatment termination) (Danoff, Cowchock et al. 1982; Ellenberg, Liu et al. 
2009; Gunn, Lahdesmaki et al. 2015). Children diagnosed with brain tumors at a younger 
age and subjected to radiation therapy, in addition to chemotherapy and surgery, are more 
likely to develop severe late-onset effects (Robinson, Fraley et al. 2013). As the survivor 
population grows, new measures to improve patient quality of life become increasingly 
important. 
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1.2 HIE 
Clinical and experimental findings underscore the evolving nature of HIE, which develops 
during the onset of the insult and encompasses the recovery period after resuscitation 
(Azzopardi, Wyatt et al. 1989; Roth, Edwards et al. 1992; Takeoka, Soman et al. 2002). 
The failure in cellular bioenergetics after ischemic insult to the immature brain displays a 
biphasic pattern (Wyatt, Edwards et al. 1989; Lorek, Takei et al. 1994; Blumberg, Cady et 
al. 1997), with an initial energy failure followed by a secondary prolonged and prominent 
energy failure over the first 48 h after reperfusion. This creates a valuable treatment 
window for the application of neuroprotective strategies to rescue injured but still viable 
brain cells. 
Mitochondria are implicated in cell damage during hypoxia-ischemia (HI) and the 
subsequent reperfusion (Kristian 2004; Hagberg, Mallard et al. 2009; Rousset, Baburamani 
et al. 2012). Mitochondrial ATP production via oxidative phosphorylation is impaired 
during ischemia. Upon reperfusion, mitochondrial function is transiently restored due to the 
resupply of cerebral oxygen, but the functional restoration is followed by delayed post-
ischemic mitochondrial respiratory failure. Several mechanisms are linked to delayed 
mitochondrial damage, particularly the induction of mitochondrial permeabilization 
(Griffiths and Halestrap 1995; Wang, Carlsson et al. 2009). Mitochondrial dysfunction then 
triggers a number of pathophysiological responses, including an accumulation of glutamate 
and the overactivation of its receptors, an increase in intracellular calcium levels, the 
generation of reactive oxygen species (ROS) and nitric oxide (NO), and the release of pro-
apoptotic proteins (Rousset, Baburamani et al. 2012).  
HI-induced excitotoxicity and oxidative damage cascades can instigate microvascular 
injury and blood-brain barrier (BBB) dysfunction, eliciting robust post-ischemic 
inflammation in the penumbra surrounding the infarct core, as evidenced by microglial 
activation (Giulian and Vaca 1993; McRae, Gilland et al. 1995) and cytokine release (Bona, 
Andersson et al. 1999). Together with apoptosis, inflammation critically participates in 
delayed neuronal cell death, and the magnitude of apoptosis and inflammation eventually 
reflects the severity of HIE. 
1.2.1 Apoptosis 
Cumulative evidence shows that brain cells die by either necrosis or apoptosis, or a 
combination of the two, based on biochemical and morphological criteria (Northington, 
Ferriero et al. 2001). Necrosis, manifested by swelling of the cytoplasm and organelles and 
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the loss of membrane integrity, is the predominant cell death mechanism initiated during 
the acute injury phase and in more severe cases of ischemic damage (Bonfoco, Krainc et al. 
1995; Towfighi, Zec et al. 1995; Carloni, Carnevali et al. 2007). By contrast, apoptosis, a 
process whereby cells require appropriate levels of intracellular ATP to commit suicide 
(Eguchi, Shimizu et al. 1997; Nicotera, Leist et al. 1998), occurs several days after the 
insult in milder cases of ischemic injury, especially within the penumbra area (Bonfoco, 
Krainc et al. 1995; Northington, Ferriero et al. 2001). Brain maturity also has an impact on 
the preferential utilization of cell death mechanisms (Zhu, Wang et al. 2005). Pro-apoptotic 
proteins are highly expressed in the developing brain and decline during neuronal 
maturation (Hu, Liu et al. 2000). Therefore, it is not surprising that the activation of 
apoptotic machinery predominates during HI-induced pathogenesis in the immature brain. 
The neuronal cell death mechanisms then shift to predominantly necrosis during brain 
development (Liu, Siesjo et al. 2004).  
Two categorized pathways have been identified to lead to apoptosis, an intrinsic and an 
extrinsic pathway. There is now considerable evidence that cerebral ischemia stimulates 
expression of Fas ligand, which is implicated in the extrinsic pathway of caspase activation 
(Rosenbaum, Gupta et al. 2000). The onset of ischemia also initiates the accumulation of 
intracellular calcium and oxidative stress, which subsequently triggers the intrinsic 
apoptotic pathway (Dirnagl, Iadecola et al. 1999). Although the triggers vary, they are all 
converged to a mitochondrion-centered control mechanism (Kroemer, Galluzzi et al. 2007). 
1.2.1.1 The BCL2 family 
The BCL2 (B-cell lymphoma 2) gene was originally identified by virtue of its deregulation 
via a chromosomal translocation commonly occurring between chromosome 14 and 18 in 
follicular B-cell lymphomas. This translocation decreases the propensity of B-cells to 
undergo apoptosis (Vaux, Cory et al. 1988). Approximately 25 BCL2 family proteins with 
a regulatory function in apoptosis have been described to date. These proteins contain at 
least one conserved BCL2 homology (BH) domain (BH1–BH4), allowing them to direct 
apoptosis through intermolecular interactions with other BCL2 family members.  
The pro-survival members of the BCL2 protein family (BCL2 and BCL-XL) contain all 
four BH domains, and are essential for cell survival and function. Contrarily, some pro-
apoptotic members of the BCL2 family (e.g., Bax and Bak) contain three BH domains, and 
are required for increasing mitochondrial permeability and releasing apoptotic regulators 
via channel or pore formation in the outer mitochondrial membrane. Other pro-apoptotic 
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BCL2 proteins (e.g., Bid) contain only the critical BH3 death domain. These one-BH 
domain proteins bind to and inhibit pro-survival BCL2 family members, thereby facilitating 
the activation of pro-apoptotic Bax and Bak proteins (Willis, Fletcher et al. 2007).  
Under normal conditions, Bax resides primarily in the cytoplasm in its monomeric form. In 
response to apoptotic stimuli, Bax translocates to the mitochondria in association with other 
Bax and/or Bak monomers to form pores in the outer mitochondrial membrane (Yethon, 
Epand et al. 2003; Dewson and Kluck 2009; George, Targy et al. 2010). Mitochondrial 
outer membrane permeabilization due to a disturbance in the balance of pro- and anti-
apoptotic members of the BCL2 family, stimulates the initiation of caspase-dependent and -
independent cell death through the release of pro-apoptotic proteins. For example, 
cytochrome c translocates to the cytosol (Northington, Ferriero et al. 2001), where it 
together with apoptotic protease-activating factor 1 and dATP drive assembly of the 
apoptosome (Gill, Soriano et al. 2002), which goes on to trigger the proteolytic caspase-9/-
3 cleavage cascade (Li, Nijhawan et al. 1997; Benjelloun, Joly et al. 2003). Meanwhile, 
AIF relocates to the nucleus and mediates large-scale DNA fragmentation through a 
caspase-independent pathway (Zhu, Qiu et al. 2003; Zhu, Wang et al. 2007). 
1.2.1.2 Caspases 
Caspases make up a family of intracellular cysteine proteases with unique substrate 
specificity, requiring an aspartate residue at the cleavage site. These proteases are essential 
for the execution of apoptosis (Stennicke and Salvesen 2000; Ferri and Kroemer 2001). The 
caspase proteins are synthesized as inactive zymogens containing three domains, a variable 
length amino-terminal prodomain, a large subunit domain (~20 kDa), and a small subunit 
domain (~10 kDa). Fourteen caspases have been identified so far, comprising the initiator 
caspases, the effector caspases, and a group of caspases involved in inflammatory cytokine 
processing. Initiator caspases (e.g., caspase-2, -8, and -9) directly catalyze the proteolytic 
maturation of effector caspases (caspase-3 and -7). In this manner, the effector caspases 
stimulate the cleavage of numerous important proteins, including structural proteins within 
the cell, eventually culminating in cellular apoptosis. Activation of inflammatory caspases 
(e.g., caspase-1, -4, -5, and -11) results in the production of pro-inflammatory cytokines 
and promotion of innate immune responses to various stimuli. 
By now, three caspase-related signaling pathways are recognized that can lead to apoptosis. 
The intrinsic apoptotic pathway involves the activation of caspase-9 via the assembled 
apoptosome, followed by caspase-3 activation (Zou, Henzel et al. 1997). Extrinsic 
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apoptosis is elicited by the activation of death receptors, inducing the formation of the 
death-inducible signaling complex (DISC). DISC in turn mediates the activation of 
caspase-8 and the downstream caspases, caspase-3 and -7 (Salvesen and Dixit 1997). 
Caspase-8 also prompts the proteolytic cleavage of Bid, followed by the generation of 
truncated Bid and the insertion of Bax or Bak into the mitochondrial membrane (Li, Zhu et 
al. 1998; Luo, Budihardjo et al. 1998). The third pathway is associated with caspase-2 
activation, also increasing mitochondrial permeabilization and the release of pro-apoptotic 
proteins (Enoksson, Robertson et al. 2004).  
Caspase activation is a prominent feature of the developing brain after HI (Hu, Liu et al. 
2000; Liu, Siesjo et al. 2004). Caspase-3 is the most abundant effector caspase present and 
predominates in apoptotic cell death in the immature brain, displaying increased activity for 
at least 6 days after HI (Wang, Karlsson et al. 2001). Notably, caspase activation appears to 
be more important for injury progression in the immature vs. adult brain (Hu, Liu et al. 
2000; Blomgren, Zhu et al. 2001). These observations support the findings that caspase 
inhibitors utilized in treatment modalities ameliorate HI-provoked neonatal brain damage.  
1.2.2 Inflammatory response 
The immune system is generally divided into the innate immune system and the adaptive 
immune system. In contrast to the nonspecific defenses afforded by the innate immune 
system, the adaptive immune system confers an antigen-specific immunity driven by 
lymphocytes and the development of immunological memory. Researchers have long 
regarded the brain (except for the meningeal compartment) as relatively isolated from 
immunosurveillance under normal conditions due to the existence of the BBB and the 
formation of an immunological barrier, as well as a limited adaptive response (Reese and 
Karnovsky 1967; Schwartz, Moalem et al. 1999). However, a recent study described the 
existence of a functional network of lymphatic vessels lying parallel to the dural sinuses, 
prompting new consideration of immune responses in the CNS (Louveau, Smirnov et al. 
2015). 
Inflammation occurs in response to various forms of CNS injury and disease, and is 
characterized by activation of microglia, astrocytes, and endothelial cells, in addition to 
enhanced expression of inflammatory mediators. The peripheral immune cells can also 
cross a permeable BBB and contribute to such a process. The relative contribution of 
systemic and local inflammation, and the link between the two, varies depending on the 
injury setting. For instance, stroke in the adult brain promotes the infiltration of peripheral 
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myeloid cells into the brain parenchyma (Dirnagl, Iadecola et al. 1999), probably by 
increasing BBB permeability and stimulating a persistent inflammatory reaction (Gidday, 
Gasche et al. 2005). 
The inflammatory process begins in the intravascular compartment at the onset of ischemia 
and progresses toward the parenchymal processes leading to brain damage over time 
(Iadecola and Anrather 2011). In the context of hypoxic-ischemic encephalopathy, 
inflammation is critical for the delayed cell death and contributes importantly to the 
progression of brain injury (Inder and Volpe 2000; Kaushal and Schlichter 2008; Liu and 
McCullough 2013). Inflammatory responses in the CNS are initially characterized by the 
activation of resident microglia. Activated microglia release reactive oxygen species (ROS), 
proinflammatory cytokines and matrix metalloproteinase 9 that cause neurotoxicity. Next, 
peripheral macrophages, monocytes, and neutrophils infiltrate the brain (Zheng and Yenari 
2004; Liu and McCullough 2013; Umekawa, Osman et al. 2015), amplifying the 
inflammatory response. 
1.2.2.1 Microglia 
Microglia are distributed throughout the brain parenchyma and form the first and main line 
of defense against insults (Stoll and Jander 1999; Nimmerjahn, Kirchhoff et al. 2005; 
Tambuyzer, Ponsaerts et al. 2009). Microglia arise from hematopoietic stem cells in the 
yolk sac that migrate to the brain during early embryonic development. Thus, microglia are 
endowed with a self-renewing capacity to sustain the resident population (Ginhoux, Greter 
et al. 2010; Schulz, Gomez Perdiguero et al. 2012; Gomez Perdiguero, Schulz et al. 2013). 
Under normal conditions, microglia search for alterations in homeostasis by constantly 
scanning the environment with dynamic cytoplasmic extensions (Nimmerjahn, Kirchhoff et 
al. 2005; Hanisch and Kettenmann 2007). By doing so, they contribute to the maintenance 
of normal CNS functions; they also play an essential role in hippocampal neurogenesis by 
phagocytosing apoptotic newborn cells (Sierra, Encinas et al. 2010).  
Under pathological conditions (e.g., HI), microglia rapidly react to activation stimuli and 
adjust their functions accordingly. In the immature rodent brain, microglial activation 
appears within 2 h after HI, reaches a peak after 2–3 days, and remains elevated until ~14 
days after the insult (McRae, Gilland et al. 1995). Additionally, a retrospective clinical 
study on postmortem brains from human neonates with proven HIE showed a dense 
infiltrate of microglial cells in the polymorphous layer of the dentate gyrus (DG) (Del Bigio 
and Becker 1994).  
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Excessive microglial activation in the developing brain exerts toxic effects by generating an 
overabundance of pro-inflammatory cytokines (tumor necrosis factor (TNF)-α, interleukin 
(IL)-1β, IL-18, and others), excitotoxic neurotransmitters, NO, and ROS (Bhalala, Koehler 
et al. 2014). The net result is disruption of the immature BBB and worsening of 
inflammation and brain damage (Bona, Andersson et al. 1999; Yenari, Xu et al. 2006; 
Kichev, Rousset et al. 2014). Systemic administration of the antibiotic minocycline affords 
neuroprotection by inhibiting microglial activation, reducing BBB disruption and the 
production of inflammatory mediators (Arvin, Han et al. 2002; Yenari, Xu et al. 2006). 
Caspases, in addition to regulating apoptosis, also participate in microglial activation, 
providing an enzymatic target for microglial inhibition (Burguillos, Deierborg et al. 2011). 
In the subacute injury phase, however, activated microglia facilitate phagocytic clearance 
of cell debris and stimulate the reorganization of neuronal circuits. Moreover, 
pharmacological depletion of microglia before neonatal stroke amplifies local inflammation 
and aggravates damage (Faustino, Wang et al. 2011), suggesting that a subpopulation of 
microglial cells are beneficial after injury and contribute to endogenous brain defenses.  
1.2.2.2 Cytokines and Chemokines 
Cytokines and chemokines produced during inflammatory responses in the CNS mediate 
the mobilization/infiltration of inflammatory cells and the initial recognition of the 
infection or injury site. For example, cytokines and chemokines orchestrate leukocyte 
recruitment, adhesion, extravasation, and localization at the site of inflammation (Saliba 
and Henrot 2001). Cytokines also induce the expression of adhesion molecules on the 
vascular endothelium (Meager 1999). The tight adherence of leukocytes to the activated 
endothelium and their directed extravasation into inflamed tissues is promoted by 
chemokines (Rot and von Andrian 2004).  
Cytokines and chemokines can be either pro- or anti-inflammatory, exacerbating or 
diminishing the immune reaction, respectively. The levels of the pro-inflammatory 
cytokines, IL-1β, IL-6 and TNF-α, are elevated in human newborns with HIE relative to 
healthy controls. IL-1β upregulation correlates positively with HIE severity (Aly, Khashaba 
et al. 2006; Liu and Feng 2010), while interference with IL-1β expression ameliorates HI-
induced brain damage and neurological deficits (Martin, Chinookoswong et al. 1994; 
Hagberg, Gilland et al. 1996). The increased expression of cytokines following HIE is also 
accompanied by upregulation of chemokines, such as macrophage inflammatory protein 
(MIP)-1α and monocyte chemotactic protein-1 (MCP-1, also called chemokine ligand 2 
(CCL2)) (Ivacko, Szaflarski et al. 1997; Bona, Andersson et al. 1999). In the neonatal brain, 
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HI stimulates the expression of CCL2 in the parenchyma at 4 h after insult, and CCL2 
upregulation continues for ~48 h (Ivacko, Szaflarski et al. 1997). CCL2 exerts powerful 
activating and recruiting effects on mononuclear phagocytes, T-cells, and B-cells, and 
contributes to the pathogenesis of acute neonatal brain injury (Chen, Hallenbeck et al. 2003; 
Hagberg, Mallard et al. 2015).  
1.2.3 Excitotoxicity 
Glutamate is the major excitatory neurotransmitter in the brain. The excitatory response is 
generated following an interaction of glutamate with ionotropic glutamate receptors termed 
ligand-gated ion channels. Excessive activation of ligand-gated ion channels causes cell 
damage and death. This process, termed excitotoxicity, is an important mechanism of 
neuronal cell death after neonatal HI (Choi and Rothman 1990). The excitatory effects of 
glutamate are exercised via activation of three major receptor types located at post-synaptic 
membranes: the N-methyl-D-aspartic acid (NMDA) receptor, the α-amino-3-hydroxy-5-
methylisoxazole-4-propionate (AMPA) receptor, and the kainic acid (KA) receptor. 
In both preclinical animal models and human infants, cellular energy depletion during HI 
promotes neural and glial membrane depolarization and glutamate release into the 
extracellular space (Hagberg, Andersson et al. 1987; Hagberg, Thornberg et al. 1993). In 
addition, energy-dependent glutamate transporters that terminate the excitatory signal via 
glutamate reuptake become impaired (Swanson, Farrell et al. 1995). This results in an 
accumulation of glutamate to excitotoxic levels and the ensuing overactivation of NMDA 
receptors, which eventually increases the intracellular influx of calcium to initiate apoptotic 
cell death.  
The immature brain is especially vulnerable to NMDA receptor activation. As an important 
trophic factor for the immature brain, glutamate promotes neuronal precursor proliferation 
and migration through NMDA receptors, as well as synaptic development and plasticity 
(McDonald and Johnston 1990; Komuro and Rakic 1993). In keeping with these functions, 
the activity of NMDA receptors changes during CNS development, resulting in a period of 
enhanced sensitivity to excitotoxic insults. In the immature brain, NMDA receptors are 
hyperactive and show enhanced density, excitability, and the capacity to provoke toxicity 
(Ben-Ari, Cherubini et al. 1988; Hamon and Heinemann 1988). In agreement with these 
findings, NMDA receptor antagonists are effective neuroprotective agents in preclinical 
animal models (McDonald, Silverstein et al. 1987). However, clinical trials studying the 
direct antagonism of NMDA receptors as a therapeutic treatment have proven 
	  
	  
9	  
disappointing, perhaps because of interference with physiological NMDA receptor function 
and/or a narrow therapeutic window (Ikonomidou and Turski 2002). 
1.2.4 Oxidative stress 
Free radicals are byproducts of normal cellular metabolism. These molecules are extremely 
reactive and can inflict damage on cells (Dawson and Dawson 1996). There are many types 
of free radicals, but those of most concern in biological systems, the ROS, are derived from 
oxygen. Under normal conditions, our biological system is able to counteract or detoxify 
ROS via antioxidant-mediated neutralization. Nonetheless, in extreme situations such as HI, 
ROS production is accelerated upon reperfusion, when oxygen is reintroduced to the 
ischemic tissue. Hence, the effectiveness of the antioxidant defense system is decreased, 
and the ROS/antioxidant balance is disturbed (Chan 2001). A major consequence of the 
resultant oxidative stress is damage to cellular macromolecules, causing fragmentation of, 
or structural changes in, lipids, proteins, and nucleic acids. The neonatal brain is 
characterized by high concentrations of unsaturated fatty acids and oxygen consumption 
rates, low concentrations of antioxidants, and the availability of redox-active iron for the 
catalytic formation of free radicals, rendering the organ particularly vulnerable to oxidative 
damage (Ferriero 2004).  
Mitochondria are a major source of ROS production in both healthy and diseased tissues, 
including those affected by HI-induced injury. Approximately 2 % to 5 % of oxygen 
utilization by resting mitochondria is lost to ROS generation, and ROS production is 
enhanced by increased electron-transport activity (Boveris and Chance 1973). In keeping 
with its high energy demands, mitochondrial respiration is higher in the brain than in most 
other organs, thus increasing the risk of elevated free radical production (Schonfeld and 
Reiser 2013). Data on mitochondria isolated from ischemic brain and from in vivo 
metabolic imaging studies suggest that ischemia-reperfusion engenders both short-and 
long-term alterations in mitochondrial function (Bainbridge, Tachtsidis et al. 2014). 
Oxidative damage to mitochondria and resulting metabolic impairment may have several 
consequences, including downregulated ATP synthesis, decreased mitochondrial membrane 
potential, and enhanced release of pro-apoptotic factors (Rousset, Baburamani et al. 2012). 
1.2.5 Neuroprotective strategies 
Numerous research efforts are directed toward the investigation of experimental therapies 
targeting specific pathways in the pathophysiology of HI-induced brain injury. 
Nevertheless, only a few of these strategies have presently met with clinical success. 
Hypothermia, when initiated within 6 h of birth, can successfully decrease mortality rates 
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and improve neurologic outcomes after moderate HIE in full-term infants, and is becoming 
a standard therapy for HIE management (Clark and Snedeker 2006; Jacobs, Morley et al. 
2011).  
The ideal aim of HIE treatment is to reduce mortality and restore long-term motor and 
cognitive deficits. A better understanding of the biochemical and cellular mechanisms 
behind HI-provoked brain damage would assist in uncovering effective interventions to 
terminate or mitigate deleterious injury cascades. In addition, the optimal therapeutic 
window for various neuroprotective strategies must be investigated to achieve maximum 
treatment efficiency, and to eventually improve the care of perinatal HI patients. In this 
regard, pharmacological interventions as well as regenerative therapies for HI have been 
proposed and evaluated (Badr Zahr and Purdy 2006). For instance, allopurinol is an 
antioxidant that inhibits the formation of free radicals. This agent can decrease HI-induced 
brain damage in experimental animal models and in the clinical environment (Palmer, 
Towfighi et al. 1993; Torrance, Benders et al. 2009). Other possible candidates for HI 
management include caspase inhibitors and anti-inflammatory drugs, which show 
neuroprotective effects even when delivered after the onset of HI-facilitated injury (Cheng, 
Deshmukh et al. 1998; Khan, Sekhon et al. 2004).  
Endogenous neurogenesis seems to increase after HI (Felling, Snyder et al. 2006; Yang, 
Covey et al. 2007). However, the attempt at neuronal repopulation appears futile, because 
the supply of endogenous stem cells is either insufficient or the number of surviving stem 
cells is too low to replace lost neurons, let alone to reconstruct the three-dimensional 
architecture of the brain (Martino and Pluchino 2006). Transplantation of stem cells into 
injured or degenerating brain regions can be beneficial in cases of acute brain damage and 
neurodegenerative disease (Lindvall, Kokaia et al. 2004; Lindvall and Kokaia 2011). 
Regardless, very few exogenous stem cells survive the transplantation process, and those 
that do survive rarely integrate into the injured brain tissue (Chen, Li et al. 2002; Menasche 
2005), thus challenging the concept of functional tissue replacement by stem cells. As such, 
the precise mechanisms underlying the therapeutic effects observed after stem/progenitor 
cell transplantation into the brain remain unclear.  
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1.3 IR-induced brain injury 
IR-induced brain injury refers to functional deficits that arise predominantly from DNA 
damage, as well as to anatomical deficits. Both may occur either directly or indirectly from 
exposure of tissues to IR (Hall 2000). IR directly damages tissue by interacting with and 
lesioning DNA. Indirect damage is attributed to the actions of ROS and reactive nitrogen 
oxide species (RNOS), which are formed from radiation/water molecule interactions. Overt 
white matter necrosis is among the most debilitating reactions to IR (Ruben, Dally et al. 
2006). However, with the improvement in radiotherapy protocols, such as divide the total 
dose of radiation into a number of small doses, these problems have been significantly 
reduced. Nevertheless, many patients exhibit progressive learning and memory deficits 
after IR with no overt injuries, especially when the radiation field involves the temporal 
lobe, where the hippocampus resides (Packer, Sutton et al. 1989; Mulhern, Merchant et al. 
2004).  
The hippocampal formation is essential for cognitive function, because it processes short-
term declarative memory and spatial information prior to long-term memory storage in the 
neocortex (Eichenbaum 2000; Eichenbaum 2001; Clark, Broadbent et al. 2007). The 
mechanisms underlying IR-provoked cognitive deficits are only partly understood, but 
probably include reduced hippocampal neurogenesis (Raber, Rola et al. 2004; Rola, Raber 
et al. 2004). Like cancer cells, neural progenitor cells are vulnerable to the effect of IR than 
normal cells given to their high proliferative capacity. At least two mechanisms causing 
reduced neurogenesis after radiotherapy are possible: 1) direct depletion of NPCs via 
apoptosis, stemming from DNA double-strand breaks, and 2) IR-induced 
neuroinflammation, which alters the microenvironment and shifts the proliferative response 
of NPCs from neurogenesis to gliogenesis (Monje, Mizumatsu et al. 2002). 
1.3.1 Hippocampal neurogenesis 
Neurogenesis, or the process whereby new neurons are generated from neural 
stem/progenitor cells, is most pronounced during the embryonic/prenatal period and 
continues throughout life (Seki and Arai 1995; Kuhn, Dickinson-Anson et al. 1996; 
Eriksson, Perfilieva et al. 1998). Neurogenesis transpires in the subventricular zone located 
in the walls of the lateral ventricles, and also in the subgranular zone (SGZ) of the 
hippocampal DG (Altman and Das 1965; Altman and Das 1967; Caviness 1973; Gueneau, 
Privat et al. 1982; Kuhn, Dickinson-Anson et al. 1996; Eriksson, Perfilieva et al. 1998). 
This thesis focuses on neurogenesis and IR effects in the SGZ.  
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Neural stem cells in the SGZ comprise a narrow layer of cells between the hilus and the 
granule cell layer (GCL), and give rise to DG granule neurons through a multistep process 
upon extrinsic and intrinsic stimulation (Goldman and Chen 2011). Newborn neurons 
integrate into, and form synapses within, the existing hippocampal circuitry, receiving 
functional inputs by extending dendrites toward the molecular layer and projecting axons 
through the hilus toward the CA3 region of the hippocampus (Hastings and Gould 1999; 
Overstreet-Wadiche and Westbrook 2006; Zhao, Teng et al. 2006). The integration process 
is stereotypic in nature and initially activated by ambient gamma-aminobutyric acid 
(GABA), followed by dendritic GABAergic and glutamatergic synaptic inputs, and finally, 
by perisomatic GABAergic inputs (Esposito, Piatti et al. 2005; Overstreet Wadiche, 
Bromberg et al. 2005; Tozuka, Fukuda et al. 2005). Although newborn neurons exhibit 
hyper-electrical and enhanced synaptic properties during immature stages, they are already 
functional (Schmidt-Hieber, Jonas et al. 2004; Ge, Sailor et al. 2008). After structural 
maturation of the newborn neurons, their electrophysiological properties become 
indistinguishable from those of adult granule cells (Ge, Yang et al. 2007; Laplagne, 
Kamienkowski et al. 2007). 
As noted above, the hippocampus is crucial for the temporal formation of memories, 
including declarative memory and spatial memory (Burgess, Maguire et al. 2002). Given 
the continuous integration of new neurons into the existing hippocampal circuitry, the 
effect of neurogenesis on hippocampus-related behavior becomes an important question. 
Several studies have shown strong positive correlations between the rate of hippocampal 
neurogenesis and performance in learning and memory tasks; furthermore, manipulation of 
hippocampal neurogenesis causes corresponding changes in cognitive performance (Epp 
and Galea 2009; Deng, Aimone et al. 2010). For example, voluntary exercise and 
environmental enrichment both increase neurogenesis and improve the performance of aged 
mice in spatial learning tasks (Kempermann, Gast et al. 2002; van Praag, Shubert et al. 
2005). However, specific ablation of adult-born hippocampal neurons via inducible gene 
expression in transgenic mice impairs hippocampal-dependent memory performance, as 
does administration of methylazoxymethanol acetate or glucocorticoid (Shors, Miesegaes et 
al. 2001; Dupret, Revest et al. 2008; Atsak, Hauer et al. 2012). Therefore, disruption of 
hippocampal neurogenesis can have severe clinical outcomes.  
Endogenous neural stem and progenitor cells seem to be particularly vulnerable to IR-
induced damage, because exposure to even a low dose of X-rays during stem cell 
proliferation can trigger DNA damage and apoptosis (Mizumatsu, Monje et al. 2003). 
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Moreover, stem cell proliferation remains depressed for prolonged periods of time, and 
newborn neurons are not capable of repopulating or regenerating the SGZ (Tada, Parent et 
al. 2000). Fukuda et al indicated that a single dose of IR (8 Gy) almost completely blocked 
the growth of the hippocampal DG, as assessed by quantification of DG size. The growth 
inhibition was accompanied by deficits in hippocampal-dependent behaviors (Fukuda, 
Fukuda et al. 2005; Karlsson, Kalm et al. 2011). Together with ablation of the precursor 
pool, IR further reduced the ability of the remaining stem cells to adopt a neuronal fate, 
probably by triggering intrinsic cellular damage and also by altering a neurogenesis-
promoting environment. In support of this idea, gliogenesis was relatively preserved 
following exposure of the brain to radiation (Monje, Mizumatsu et al. 2002). The persistent 
and progressive impairment of neurogenesis after IR has been linked to the deleterious 
effects of chronic inflammation (Monje, Mizumatsu et al. 2002).  
1.3.2 IR-induced neuroinflammation 
Appropriate regulation of neuroinflammation facilitates CNS recovery by containing and 
eliminating noxious stimuli while initiating tissue repair. Despite these efforts, prolonged 
neuroinflammation can induce secondary injury and harm the developing brain. 
Compelling evidence suggests that IR provokes a chronic state of inflammation and affects 
the fate of the precursor cell pool by altering the surrounding microenvironment. 
Importantly, irradiated precursor cells can still differentiate into neurons in vitro when 
given the requisite proliferative signals (Monje, Mizumatsu et al. 2002). Therefore, anti-
inflammatory treatment can restore neurogenesis, at least in part, and mitigate IR-induced 
cognitive deficits (Monje, Toda et al. 2003; Jenrow, Brown et al. 2013).  
Macrophages are an important type of leukocyte involved in directing immune responses. 
These cells were first discovered in 1884 by Élie Metchnikoff, a Russian bacteriologist, and 
derive their name from the Greek term for “big eaters”. As scavengers, macrophages 
primarily function to engulf and digest invading pathogens, cell debris, and apoptotic cells 
in a process called phagocytosis. In addition, macrophages are capable of responding 
rapidly to injury conditions, express a plethora of chemical substances and mediators to 
regulate inflammatory processes, and help to establish adaptive immunity by recruiting 
other immune cells (Fujiwara and Kobayashi 2005; Dheen, Kaur et al. 2007). Macrophages 
are found in essentially all tissues. In the CNS, microglia represent the resident 
macrophages.  
Macrophages can either increase inflammation and stimulate the immune system, or 
decrease inflammation and dampen immune reactions through the release of specific 
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cytokines (Dalton, Pitts-Meek et al. 1993; Gordon 2003; Butterfield, Best et al. 2006). For 
decades, CNS macrophages were regarded as a functionally homogeneous population due 
to the existence of the BBB, and invulnerable to peripheral leukocyte entry. (Wilson, 
Weninger et al. 2010). However, an abundance of data now demonstrates that the 
macrophage population in the injured brain consists of both resident microglia and 
infiltrating monocyte-derived macrophages (Shechter, London et al. 2009; Jin, Yang et al. 
2010). Furthermore, the latter perform indispensable roles that cannot be provided by their 
resident counterparts (Shechter, London et al. 2009; Shechter, Raposo et al. 2011). 
Nonetheless, whether peripheral macrophages contribute to the persistent negative effects 
of IR remains unknown and requires elucidation. 
Monocytes expressing the chemokine receptor CCR2 are selectively recruited to injured 
tissue in response to CCL2, where they become macrophages (Auffray, Fogg et al. 2007). 
The finding that CCL2 deficiency is sufficient to restore hippocampal neurogenesis after IR 
suggests that pro-inflammatory monocytes may contribute to chronic IR-induced 
neuroinflammation (Lee, Haditsch et al. 2013). However, given the lack of specific markers, 
it is difficult to distinguish resident microglia from infiltrating macrophages derived from 
blood-borne, peripheral monocytes via conventional techniques. Moreover, little is known 
about the relative contributions of resident microglia and infiltrating macrophages to the 
inflammatory response in the CNS at different maturation stages. A better understanding of 
these two evolutionarily distinct groups of antigen-presenting cells will be important in the 
search for efficient clinical interventions for IR-induced brain damage.   
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2 Aims of the thesis 
The overall goal of this thesis was to investigate the contributions of apoptosis and 
inflammation to the development of HI- and IR-induced brain injury, and to explore 
potential neuroprotective therapies for each condition.  
Four specific aims were addressed: 
I.  To determine the neuroprotective effect of a cell-penetrating Bax-inhibiting peptide 
(BIP) after HI in neonatal mice. 
 
II. To investigate the effects of delayed, long-term administration of the caspase inhibitor, 
Q-VD-OPh, on apoptosis and inflammation after HI in neonatal mice. 
 
III. To evaluate the neuroprotective potential of the conditioned medium (CM) obtained 
from apoptotic NPCs both in vitro and in vivo. 
 
IV. To characterize the relative contributions of resident microglia and infiltrating 
macrophages in the inflammatory response after IR in both juvenile and adult brains. 
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3 Methods 
This section briefly describes the most important methods used in this thesis. For detailed 
information regarding specific experimental procedures, please refer to the Materials and 
Method section of each individual manuscript. 
3.1 Animals (I-IV) 
Manuscripts I, II, and III describe the use of C57BL/6 mice to produce a neonatal HI model 
to compare the efficacy of different therapeutic interventions. Strain differences in the 
susceptibility to brain damage were previously documented in a study of neonatal mouse 
HI models. In particular, CD1 and 129Sv mice were quite susceptible or enormously 
resistant to HI insult, respectively, whereas C57BL/6 mice were intermediately sensitive 
and showed an increasing degree of brain damage with the increasing duration of hypoxia 
(Sheldon, Sedik et al. 1998). For this reason, the C57BL/6 mouse was chosen for the 
present HI studies.  
Manuscript IV describes the use of genetically modified CX3CR1GFP/+CCR2RFP/+ mice with 
a C57BL/6 background for the IR study. Resident microglia (CX3CR1+) were labeled in 
these animals with green fluorescent protein (GFP), and monocytes 
(Ly6ChiCCR2+CX3CR1− cells) were labeled with red fluorescent protein (RFP) (Saederup, 
Cardona et al. 2010). The advantage of this reporter system is that resident microglia are 
readily distinguished from infiltrating monocyte-derived macrophages, allowing 
determination of the relative contribution of each population to the inflammatory response 
after IR. 
Given the difference in brain anatomy between mice and humans, it is difficult to 
extrapolate the maturational age of the murine CNS to that of the human. Recent work 
compared five key events (neuroanatomy, cell proliferation, synaptogenesis, myelination, 
and inflammation) that accompany brain development in rodents and humans, and 
concluded that rodent at postnatal day (PND) 7–10 and 60 are equivalent to term infants 
and adult humans, respectively (Semple, Blomgren et al. 2013).  
3.2 HI model (I-III) 
The most commonly used neonatal HI model was modified in the early 1980s from the 
Levine technique (Levine 1960) for use with PND 7 rats (Rice, Vannucci et al. 1981; 
Vannucci and Vannucci 1997), and was later adapted again for use with PND 9 mice 
(Sheldon, Sedik et al. 1998). This model consists of unilateral common carotid artery 
ligation followed by a period of systemic hypoxic exposure. Ligation alone is insufficient 
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to induce brain injury in rodents, because these animals have extensive collaterals. 
However, when combined with hypoxia, the animals undergo a dramatic decrease in 
systemic blood pressure and cerebral blood flow, as well as a compensatory vasodilation of 
the vessels, instigating a reduction of regional blood flow to the ipsilateral hemisphere and 
the development of global cerebral ischemia. Cerebral blood flow is restored to control 
levels immediately upon return to a normoxic environment (Vannucci and Hagberg 2004).  
The brain damage incurred in the above model is restricted to the ipsilateral hemisphere, 
leaving the contralateral hemisphere unaffected. Therefore, the contralateral hemisphere 
serves as an internal control (Grafe 1994; Towfighi, Housman et al. 1994). Animals that 
survive the insult generally live as long as normal animals, permitting assessment of the 
impact of various therapeutic interventions both histologically and functionally. The 
drawbacks of this model are the lack of multi-organ dysfunction and high variability (Grafe 
1994; Hagberg, Bona et al. 1997). The latter limitation is circumvented by including a large 
number of animals in each experimental group. 
3.3 IR model (IV) 
PND 10 (juvenile) or PND 90 (adult) mice of both genders were used for the IR procedure. 
Animals were placed onto a carved Styrofoam bed adjusted for body size with a source-to-
sample distance of 50 cm in an X-RAD 320 Biological Irradiator (Precision X-Ray, North 
Branford, CT, USA) and anesthetized with isoflurane (5 % for induction and 2 % for 
maintenance). The entire brain was covered by a radiation field of 2 cm × 2 cm (dose rate = 
0.72 Gy/min at 320 kV and 12.5 mA). A single dose of 8 Gy was delivered, yielding a time 
for the IR procedure of 11 min and 3 sec. The total procedure, including induction of 
anesthesia, required ~13 min for each animal. Sham control animals were anesthetized but 
not subjected to IR. The dose applied to the experimental animals was equivalent to 18 Gy 
delivered in 2 Gy fractions, a treatment protocol described for prophylactic IR in selected 
cases of acute childhood lymphatic leukemia (Fowler 1989). 
3.4 Cell culture and preparation of conditioned medium (CM, III) 
Mouse NPCs were provided by Professor Fred H. Gage (Salk Institute, La Jolla, CA, USA) 
(Ray and Gage 2006). Cells were cultured in Dulbecco’s Modified Eagle’s Medium 
supplemented with nutrient mixture F12 in a standard humidified tissue culture incubator at 
37°C and 5 % CO2 (Sato, Shinjyo et al. 2013). SNL 76/7 feeder cells were obtained from 
Sigma-Aldrich (St. Louis, MO, USA). HT22 hippocampal neuronal cells were originally 
generated by David Schubert (Salk Institute, San Diego, USA) and obtained from Gerald 
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Thiel (Homburg-Saar) Primary mouse embryonic fibroblasts (MEFs) were obtained from 
embryonic day 17–18 C57BL/6 mice. MEFs, SNL cells, and HT22 cells were cultured 
according to established protocols.  
CM was procured from NPCs, MEFs, SNL cells, and HT22 cells. Cells were grown in 
tissue culture flasks until they reached ~70 % confluency. Culture media were removed, 
and cells were washed once with PBS. Next, the cells were treated with Earle’s Balanced 
Salt Solution with or without phenol red (Sigma-Aldrich) to induce starvation. CM samples 
were collected, centrifuged at 1,000 rpm for 10 min, and filtered through a 0.22-µm 
membrane filter to remove dead cells and cellular debris. The filtered samples were heated 
at 60°C for at least 10 min for heat activation. To test the ability of secreted cellular 
components to safeguard hippocampal neurons against glutamate toxicity in vitro, HT22 
cells were pretreated with the various heat-inactivated CM samples for 6 h, followed by 
glutamate treatment in the continued presence of the individual CM fractions. 
 
3.5 Behavioral evaluation (I and II) 
HI-induced brain damage is observed in the cerebral cortex, striatum/thalamus, 
hippocampus, and subcortical/periventricular white matter (Rice, Vannucci et al. 1981; 
Vannucci and Hagberg 2004). Surviving neural tissue surrounding the lesion cannot fulfill 
the extremely high regenerative demands of the brain, exemplified by deficits in both motor 
and cognitive functions. In this thesis work, behavioral assessments after HI were 
conducted by applying the cylinder-rearing test, the open-field test, and trace-fear 
conditioning test. 
The cylinder-rearing test was first designed for evaluating locomotor asymmetry in 
Parkinson’s disease model rats, and was later adapted to other animal models for assessing 
sensorimotor asymmetry (Iancu, Mohapel et al. 2005; Brooks and Dunnett 2009). The 
animals are placed in an open-top glass cylinder, and filmed with video equipment from the 
side. Forelimb activity while rearing against the wall is recorded, and forelimb use is 
defined by the contact of the entire palm against the wall during rearing or lateral 
exploration, indicating the use of the palm for body bearing. Paw usage is calculated as a 
percentage by measuring the number of impaired forelimb wall contacts subtracted from 
the number of contacts for the contralateral paw, divided by the total number of contacts. 
The open-field test is a simple test of locomotor activity involving the observation of an 
animal’s movements within an open arena (Nilsson, Markinhuhta et al. 2006). When placed 
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in an unfamiliar field, a mouse will typically explore the whole arena while keeping close 
to the walls. Once the animal becomes habituated to the environment, it increasingly moves 
from one wall to another by crossing the central portion of the arena. Here, the number of 
stops and time spent in the middle of the arena were recorded and later analyzed with 
Ethovision 3.1 video-tracking software (Noldus Information Technology Inc., Leesburg, 
VA, USA). The analysis produces a behavioral track record, allowing determination of the 
total distance traveled during the observation period, as well as evaluation of attention-
deficit hyperactivity disorder after HI.  
Trace-fear conditioning is an associative learning task employed for the assessment of 
hippocampus- and amygdala-dependent learning deficits in rodents (Clark and Squire 1998; 
Goosens and Maren 2001). In this test, animals are subjected to a neutral conditioned 
stimulus (CS, such as a tone) that is paired with an aversive unconditioned stimulus (US, 
such as a foot shock). The CS and US are presented at discrete time points, and are 
separated by a stimulus-free trace interval. Once the animals learn to associate the CS with 
subsequent presentation of the US, the CS alone will elicit specific behavioral responses 
(e.g., freezing behavior, defined as the absence of movement except for respiration).  
3.6 Immunohistochemistry (I-IV) 
Paraffin sections (manuscripts I–III) were deparaffinized in xylene and rehydrated in a 
series of graded ethanol solutions. Antigen retrieval was performed by heating the slides in 
10 mM sodium citrate buffer, pH 6.0, for 10 min. After blocking, sections were incubated 
for 60 min with primary antibodies diluted in PBS, and then incubated for 60 min with 
biotinylated secondary antibodies diluted in PBS. After blocking endogenous peroxidase 
activity with 3 % hydrogen peroxide, antigen staining was visualized by using an ABC Kit 
(Vector Laboratories, Burlingame, CA, USA) and 3,3’-diaminobenzidine. In manuscript 
IV, free-floating sections were rinsed with Tris-buffered saline (TBS; 50 mM Tris-HCl in 
150 mM NaCl, pH 7.5) and incubated with 10 mM sodium citrate at 80°C for 30 min for 
antigen retrieval. The sections were then incubated in blocking solution (3 % donkey serum 
in TBS containing 0.1 % Triton X-100) for 1 h at room temperature (RT), followed by 
incubation with primary antibodies overnight at 4°C. On the second day, the sections were 
rinsed three times with TBS, incubated with the appropriate fluorophore-conjugated 
secondary antibodies for 1 h at RT, and mounted in Prolong® Antifade Mountant with 
DAPI (Life Technologies, Carlsbad, CA, USA). 
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4 Results and discussion 
4.1 Bax inhibiting peptide (BIP) reduces neonatal HI brain injury (I) 
To evaluate whether HI stimulates Bax translocation and activation, neonatal mouse brain 
sections were stained with an anti-Bax antibody (6A7) that primarily detects the pro-
apoptotic Bax conformation (Yethon, Epand et al. 2003). An early progressive increase in 
6A7 Bax immunostaining was observed after HI. This finding, together with data showing 
that a) Bax gene deficiency confers neuroprotection and b) Bax functions in mitochondrial 
permeabilization in vivo and in vitro (Gibson, Han et al. 2001; Wang, Carlsson et al. 2009), 
strongly indicates that Bax is a potential target for pharmacological neuroprotection of the 
immature brain.  
Ku70 is a critical component of the Ku70/80 complex required for nuclear repair of DNA 
double-strand breaks. The cytosolic levels of Ku70 reportedly decrease in response to 
apoptotic stimuli, prompting the dissociation of Ku70 from Bax (Gama, Yoshida et al. 
2006). This dissociation in turn elicits Bax-dependent mitochondrial permeabilization, and 
initiates caspase-dependent and -independent cell death through the release of pro-apoptotic 
proteins (Li, Nijhawan et al. 1997; Northington, Ferriero et al. 2001; Benjelloun, Joly et al. 
2003; Zhu, Qiu et al. 2003). BIP is derived from the Bax-binding domain of Ku70 and 
exists in the cytosol, where it binds and inhibits Bax (Nothwehr and Martinou 2003; 
Gomez, Gama et al. 2007). We therefore investigated the effects of BIP on apoptosis after 
HI insult.  
Injection of BIP into the brain ventricles via intracerebrovascular (ICV) administration just 
prior to the onset of hypoxia reduced Bax activation/Bax 6A7 staining at 1.5 and 3 h after 
HI. The decrease in Bax 6A7 staining was accompanied by reduced AIF translocation at 3 h 
after HI, diminished cytosolic cytochrome c immunoreactivity at 6 h, and downregulated 
caspase-3 activity at 24 h. These findings suggest that Bax activation is required for 
mitochondrial permeabilization and the subsequent release of pro-apoptotic proteins and 
downstream activation of executioner caspases in neonatal HI. Histological analysis 
demonstrated that BIP reduced HI-induced brain injury in terms of infarction volume and 
tissue loss in the entire hemisphere and specifically in the white matter at 5 days after the 
insult. Furthermore, evaluation of injury severity via neuropathological scores showed that 
BIP-facilitated neuroprotection was at its highest in the cortex and striatum. The 
neuroprotective actions of BIP were sustained over time, as evidenced by a continued 
reduction in tissue loss at 7 weeks after HI.  
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HI-induced brain damage can engender substantial long-term neurobehavioral deficits in 
sensorimotor as well as cognitive function (Jansen and Low 1996; Bona, Johansson et al. 
1997; Ikeda, Mishima et al. 2001; Ten, Bradley-Moore et al. 2003). Neuroprotective 
strategies that exert morphological protection do not necessarily ameliorate the decline in 
functional activity (Farrell, Evans et al. 2001). Therefore, it is important to assess 
neurological function along with morphological outcomes. Here, the cylinder-rearing and 
trace-fear conditioning tests were used evaluate locomotor asymmetry and associative 
learning, respectively, at 7 weeks after HI. Consequently, BIP delivered before HI 
significantly improved functional performance in both tests relative to the vehicle control.  
Altogether, the data in aim I/manuscript I demonstrate that BIP administered immediately 
before HI reduced gray and white matter injury and enhanced sensorimotor and cognitive 
function. The neuroprotection afforded by the peptide was associated with the inhibition of 
Bax-dependent mitochondrial permeabilization and the release of pro-apoptotic proteins.  
However, there are potential limitations to this approach that hinder its translation into 
clinical applications. First, BIP was given prior to the onset of HI, yet in the clinical setting, 
HIE diagnosis is based on physical and neurological exams, as well as on the results of 
laboratory tests that can only be performed after birth (Azzopardi, Strohm et al. 2009). 
Interventions are applied even later. Therefore, further clinical application-related 
investigation (i.e., post-HI BIP administration) is required to validate the histological and 
functional effects of the peptide. Second, BIP was delivered directly into the lateral 
ventricles, because of the poor bioavailability of neuropeptides to the brain, high clearance 
by the liver, and the presence of the BBB (Egleton and Davis 2005). Nevertheless, ICV 
administration is an invasive approach, and should be avoided for possible clinical 
development of peptide drugs, especially in light of alternative strategies designed to 
improve bioavailability and BBB transport of such compounds (Pardridge, Buciak et al. 
1991; Egleton, Mitchell et al. 2000). Future research is thus required elucidate BIP efficacy 
when delivered by less invasive routes (i.e., intravenous or intraperitoneal). 
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4.2 Role of caspases in apoptosis and inflammation after neonatal 
HI-induced brain injury (II) 
Caspase-3 is a key executor of apoptosis in the developing brain after HI (Blomgren, Zhu et 
al. 2001; Wang, Karlsson et al. 2001; Zhu, Wang et al. 2005). Application of caspase 
inhibitors before or at the onset of the insult is an effective treatment for HI-induced brain 
injury (Renolleau, Fau et al. 2007; Zhu, Wang et al. 2007). Considering that apoptotic 
neuronal death is a relatively slow, multistep process, HI pathology might provide a 
prolonged window for therapeutic interventions (Beilharz, Williams et al. 1995; 
Northington, Ferriero et al. 2001). Moreover, caspase signaling purportedly regulates 
microglia activation (Burguillos, Deierborg et al. 2011), which may then aggravate brain 
damage (Bona, Andersson et al. 1999; Kichev, Rousset et al. 2014). Therefore, we next 
investigated the impact of delayed, long-term administration of the caspase inhibitor, Q-
VD-OPh, on apoptosis and inflammation after neonatal HI-provoked brain injury. 
Delayed administration of Q-VD-OPh initiated at 12 h after HI decreased HI-induced 
caspase-3 activity by 23 % and total brain tissue loss by 31 %. However, the decrease in 
caspase activity was lower than that observed in our previous work (57 %), where Q-VD-
OPh was applied at the onset of and immediately after HI (Zhu, Wang et al. 2007). 
Additionally, administration of a less potent pan-caspase inhibitor, boc-aspartate 
fluoromethylketone (BAF), at 3 h after HI successfully decreased caspase-3/caspase-3-like 
activity by 50 % (Cheng, Deshmukh et al. 1998). These results suggest that much of the 
caspase activation after HI already occurs at 12 h after the insult, and that the attenuated 
enzyme inhibition observed herein (23 %) was probably due to the delayed onset of 
treatment.  
This supposition is supported by the 48 % reduction in tissue loss reported in our earlier 
work after only two injections of Q-VD-OPh, while in the current study, a 31 % reduction 
in tissue loss was noted at 4 months after HI and 14 Q-VD-OPh injections. Nevertheless, it 
must be emphasized that the interval between HI and the evaluation of brain injury was 
very different in the two studies (3 days vs. 4 months). Taking into account the progressive 
nature of HIE, an accurate comparison will require evaluation of tissue loss at 4 months 
after HI and with two injections of Q-VD-OPh. 
In addition to inhibiting caspase activation, Q-VD-OPh may overturn certain aspects of HI-
induced brain injury by reducing inflammation. Cytokines and chemokines produced by 
resident immune cells, mainly microglia, trigger reactive changes in the damaged brain. 
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Some of these inflammatory mediators, such as CCL2 and CCL3, are pro-inflammatory 
and guide monocytes/macrophages toward the ischemic area, intensifying cerebral injury 
(Kim, Gautam et al. 1995). Others, like IL-4 and IL-10, are anti-inflammatory (Vila, 
Castillo et al. 2003) and exert protective or regenerative actions after ischemic brain injury 
(Spera, Ellison et al. 1998; Xiong, Barreto et al. 2011). Accordingly, we assayed the 
expression levels of CCl2, CCL3, IL-4, and IL-10 at 48 h after HI and quantified the 
number of microglia 4 months later. Two injections of Q-VD-OPh decreased CCL2 and 
CCL3 expression levels by 29.3 and 29.1 %, respectively, but did not alter IL-4 or IL-10 
content. Long-term Q-VD-OPh treatment also failed to alter microglia density or 
morphology, and all discerned microglia displayed a ramified, surveillance morphology.  
The role of Q-VD-OPh in post-ischemic inflammation is unclear. In light of recent findings 
demonstrating that microglial activation requires caspase activation (Burguillos, Deierborg 
et al. 2011), we speculate that the agent might reduce microglia-mediated inflammation, 
particularly because the anti-inflammatory cytokines, IL-4 and IL-10, were unaffected by 
its administration. Whether Q-VD-OPh-mediated caspase inhibition in microglia 
specifically blocks formation of the pro-inflammatory M1 phenotype as opposed to the 
regenerative M2 phenotype is unknown. Alternatively, the lower levels of pro-
inflammatory chemokines observed following Q-VD-OPh treatment may simply be 
secondary to the prevention of tissue loss. Investigation of the anti-inflammatory 
mechanism of Q-VD-OPh will require detailed time courses of cytokine expression levels 
and caspase-3 activity in the presence or absence of caspase inhibition. 
We utilized the cylinder-rearing and open-field tests to evaluate functional performance 
after caspase inhibition. Q-VD-OPh treatment ameliorated HI-induced loss of sensorimotor 
function and reduced HI-induced hyperactivity at 3 and 7 weeks, respectively, after the 
insult. The current study differs from previous reports of Q-VD-OPh treatment in ischemia-
induced brain injury, in that long-lasting neurobehavioral outcomes were assessed as well 
as short-term consequences. After PND 60, when brain development in the rodent is 
complete (Semple, Blomgren et al. 2013), the two functional tests were repeated. 
Disappointingly, the functional improvements conferred by Q-VD-OPh at 3 and 7 weeks 
were no longer observed. The mechanisms underlying the discrepancy between the long-
term reduction in tissue loss and the transient functional protection remain to be 
determined.  
Several magnetic resonance imaging studies in human infants showed that 
neurodegeneration in multiple integrated brain regions evolves over time after the initial HI 
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insult (McKinstry, Miller et al. 2002; Stone, Zhang et al. 2008). Moreover, transplantation 
of mesenchymal stem cells in a mouse model of HI markedly ameliorated sensorimotor 
deficits and decreased brain tissue loss, but analogous to our findings, long-term functional 
impairment still persisted (van Velthoven, Kavelaars et al. 2010). Thus, even though Q-
VD-OPh reduced long-term tissue loss in the current study, neurobehavioral deficits after 
HI were probably merely postponed. 
  
	  
	  
25	  
4.3 Neural stem cell-based interventions for neonatal HI-induced 
brain injury (III) 
Stem cell-based therapies reportedly promote recovery in animal models of acute brain 
damage or neurodegenerative disease (Lindvall, Kokaia et al. 2004; Lindvall and Kokaia 
2011). However, the number of stem cells that survive the transplantation process is quite 
limited, and even fewer integrate into the injured brain tissue (Menasche 2005; Silva, 
Litovsky et al. 2005). These observations calling into question the notion that transplanted 
stem cells replace functional tissue.  
Here, we provide evidence that apoptotic NPCs release critical components that promote 
neuroprotection. We first confirmed that grafted NPCs undergo apoptosis as early as 6 h 
after HI. Viable NPCs are no longer detectable at 7 and 14 d after the insult, suggesting that 
the transplanted cells do not integrate into the circuitry of the injured brain. Next, growth 
factors were withdrawn from NPCs in vitro in an attempt to mimic the inhospitable 
environmental conditions after NPC transplantation in vivo. Such growth factor withdrawal 
induced cell death in the cultured NPCs within 24 h.  
Treating cultured neurons with conditioned medium (CM) generated by NPCs undergoing 
caspase-dependent cell death preserved mitochondrial integrity and function. Moreover, 
CM-treated neurons were protected from both glutamate-induced toxicity and trophic factor 
withdrawal. In contrast, medium that was obtained from NPCs that were growth factor‒
deprived and rescued using the caspase inhibitor Q-VD-OPh failed to confer 
neuroprotection, indicating that caspase-dependent NPC death—and their release of 
protective components—are required for mediating the observed protective effects of the 
resulting CM. Importantly, protection was observed in CM harvested specifically from 
apoptotic cells that were neuronal in origin, including NPCs and immortalized hippocampal 
neurons; in contrast, medium obtained from other cell types, including Mesc, MEFs, SNL 
feeder cells did not provide protection.	   This finding engenders a new concept of 
neuroprotection through the death of progenitor cells, in contrast to previous views linking 
the defensive effects of progenitor or stem cell therapies to tissue replacement and/or 
functional integration of transplanted cells into injured host neural networks. This concept 
is further supported by our results obtained using an in vivo model of cerebral 
hypoxia/ischemia, in which an intraventricular injection of NPC-derived CM confers robust 
neuroprotection, avoiding the need for cell transplantation. 
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We next identified protein constituents as the main mediators of neuroprotection in NPC-
derived CM, and attributed the protective properties of the medium to the combination of 
peroxiredoxin-1 (prdx-1) and galectin-1. Because protein synthesis inhibitors did not affect 
the neuroprotective capacity of CM rescued from dying NPCs, the bioactive proteins were 
presumably already expressed in NPCs under standard culture conditions and released upon 
apoptotic stress. The proposed ability of apoptotic cells to provide defensive signaling cues 
to surrounding cells has been previously suggested in other settings, such as β-cell mass 
regeneration (Bonner, Bacon et al. 2010), wound healing with inhibition of inflammation 
(Li, Huang et al. 2010), and planarian regeneration (Pellettieri, Fitzgerald et al. 2010). The 
actions of apoptotic cells to rescue surrounding cells in invertebrates as well as vertebrates 
indicates a fundamental and evolutionarily conserved regeneration mechanism underlying 
the protective potential of stem/progenitor cells. 
Most intriguingly, incubation at 60–80°C significantly increased the neuroprotective 
capacity of NPC-derived CM, suggesting that the bioactive protein constituents are stable at 
temperatures up to 80°C. This finding agrees with the identification of galectin-1 and prdx-
1 in the CM, which retain their activity at 60°C. Nonetheless, the increase in 
neuroprotective potential after incubation at high temperatures could be also explained by 
heat denaturation of proteins and enzymes that otherwise mediate inhibitory or even toxic 
effects. The identification of both protective and inhibitory components in NPC-derived 
CM requires further investigation.  
Our MALDI-TOF (matrix-assisted laser desorption ionization time of flight) mass 
spectrometry analyses detected prdx proteins in all investigated neuroprotective CM 
samples. Prdx proteins comprise a family of small (22–27 kDa) non-seleno peroxidases 
with six mammalian isoforms. Their role as antioxidants stems from their capacity to 
reduce and detoxify hydrogen peroxide, peroxynitrite, and a wide range of organic 
hydroperoxides (Wood, Schroder et al. 2003). The physiological importance of the prdx 
proteins is illustrated by their abundance, as well as by loss-of-function studies in knockout 
mice (Neumann, Krause et al. 2003; Yang, Rabinovich et al. 2008; Yang, Song et al. 2011). 
In the CNS, prdx proteins are thought to act as free radical scavengers and are capable of 
protecting a variety of cell types as reported in in vitro models of ischemic neuronal death, 
overexpression models and neurodegenerative diseases (Boulos, Meloni et al. 2007; Fang, 
Nakamura et al. 2007; Hattori and Oikawa 2007; Botia, Seyer et al. 2008; Smith-Pearson, 
Kooshki et al. 2008).  
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Our experiments using recombinant prdx-1 support the notion that prdx-1 has 
neuroprotective properties. However, an anti-prdx-1 antibody only partially overturned the 
protective effects of the medium, confirming that other components contribute to the 
protective effects of CM. For example, galectin-1 was also identified in NPC-derived CM. 
Galectins function in the cytoplasm, where they regulate signal transduction pathways via 
protein-protein interactions, independent of their lectin activity. Galectins can also be 
released, where their extracellular functions are mainly dependent on their sugar-binding 
lectin capacity (Yang, Rabinovich et al. 2008). Galectin-1, for its part, can assume many 
roles, including in immune responses, tumor formation, and CNS, peripheral nervous 
system, and muscle tissue development. In neural cells, galectin-1 promotes proliferation of 
neural stem cells (Sakaguchi, Imaizumi et al. 2010), drives neurite outgrowth (Puche and 
Key 1995), enhances axonal regeneration (Horie, Inagaki et al. 1999) and inhibits 
glutamate toxicity (Lekishvili, Hesketh et al. 2006) and neuronal death in a mouse model of 
amyotrophic lateral sclerosis (Chang-Hong, Wada et al. 2005). 
In summary, our findings offer an alternative explanation for the beneficial effects observed 
after NPC transplantation in brain injury paradigms, where NPC death is an essential step 
in the release of protective proteins mediating neuroprotection. From a clinical perspective, 
we suggest that conditioned medium derived from NPCs has high therapeutic potential, 
avoiding the complications associated with the transplantation of stem/progenitor cells. 
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4.4 Involvement of monocyte-derived macrophages in the 
inflammatory response after IR (IV) 
The persistent and even progressive (Bostrom, Kalm et al. 2013) impairment in 
neurogenesis after IR has been linked, at least in part, to the deleterious impact of chronic 
inflammation (Monje, Mizumatsu et al. 2002; Monje, Toda et al. 2003). The second part of 
this thesis shows that IR can induce a state of chronic inflammation in the immature and the 
adult brain, which is probably mediated by astrocytes and microglia, but not by peripheral 
macrophages. 
CCL2 regulates BBB permeability and recruits neutrophils and macrophages to injury sites 
under multiple pathological conditions (Sheehan, Zhou et al. 2007). In this manner, the 
chemokine plays an important role in directing the inflammatory response, and increased 
CCL2 expression is associated with decreased neurogenesis (Villeda, Luo et al. 2011). In 
aim IV/manuscript IV, we demonstrated that CCL2 expression peaked at 6 h after IR and 
decreased thereafter. In contrast to previous studies showing a return of CCL2 content to 
baseline levels within 24 h after injury (Kalm, Fukuda et al. 2009; Lee, Haditsch et al. 
2013), our results showed upregulation of the chemokine for as long as 1 month after IR, 
indicative of a chronic, radatiation-induced inflammatory process in both juvenile and adult 
brains.  
CCL2 is expressed by many types of cells, including microglia, astrocytes, and endothelial 
cells (Luo, Laning et al. 1994; Hayashi, Luo et al. 1995; Thibeault, Laflamme et al. 2001). 
We previously found that CCL2 expression induced by IR in the juvenile rat brain was 
mainly restricted to astrocytes, with some expression in microglia (Kalm, Fukuda et al. 
2009). Considering the transient nature of microglial activation after injury in juvenile as 
well as adult brains, we speculate that the initial burst in CCL2 expression was due to 
reactive microglia, whereas chronic CCL2 expression stemmed from other cells (e.g., 
astrocytes).  
We found no evidence for the recruitment of peripheral monocytes into either the juvenile 
or adult hippocampus for at least 1 month after IR, possibly due to maintenance of BBB 
integrity. In support of this hypothesis, an earlier study employing high-dose radiation (20 
Gy in a single dose) reported increased BBB permeability and the presence of adherent 
leukocytes in pial vessels, but not after subjection of animals to relatively low-dose 
radiation (5 Gy) (Yuan, Gaber et al. 2003). On the other hand, our results and those of 
others demonstrated BBB disruption and massive peripheral monocyte-derived macrophage 
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invasion in models of more pronounced tissue injury, such as after severe ischemia 
(Tanaka, Komine-Kobayashi et al. 2003; Umekawa, Osman et al. 2015).  
Upon IR, the adult vs. juvenile brain underwent a milder and relatively transient microglial 
activation in the GCL, as assessed by comparatively lower CCL2 expression levels and 
reduced microglial density, proliferation, morphology, and expression of CD68. The 
diminished microglial response probably reflected the lower level of neurogenesis in the 
mature brain and consequently, fewer dying neural stem and progenitor cells after exposure 
to radiation. Microglia rapidly proliferate during injury-induced activation (Dihne, Block et 
al. 2001; Kato, Takahashi et al. 2003), and accordingly, we quantified proliferating 
microglia by assessing double-positive cells for Ki-67 and CX3CR1GFP/+. We found that the 
number of proliferating microglia contributed to 50 % of the microglial increase in the GCL 
of the immature brain at 6 h after IR. A further increase in microglial numbers at 1 day after 
IR was most likely due to microglial migration from the molecular layer (ML) to the GCL, 
because scarcely any proliferating microglia were observed at this time point. Moreover, 
microglial numbers in the ML decreased without any signs of microglial cell death.  
Neurogenesis was virtually eliminated by IR in the adult brain, and very few Ki-67-positive 
cells were observed at either 6 h or 1 day after IR. None of the Ki-67-positive cells co-
localized with CX3CR1GFP-positive cells, signifying an absence of microglial proliferation. 
An observed increase in microglial density at 6 h after IR in the adult brain was probably 
not due to microglial migration from neighboring areas parts of the DG, because no 
decrease in microglial number was observed in the hilus or the ML. Still, the possibility of 
migration from other parts of the hippocampus or brain cannot be excluded.  
Little is known about the mechanism(s) behind the decrease in microglial density during 
the late injury phase following IR. Possible mechanisms include microglial migration away 
from injury sites (Giulian, Chen et al. 1989; Angelov, Gunkel et al. 1995) and cell death 
(Gehrmann and Banati 1995; Dihne, Block et al. 2001; Kalm, Lannering et al. 2009). In this 
work, however, the decreased microglial density at later time points apparently did not 
result from IR-induced apoptosis, because no active caspase-3- or TUNEL-positive 
microglia were found in the DG at 6 h or 1 day after IR. Additional research on microglial 
migration and other modes of microglial death is required to explain the observed changes 
in microglial numbers. 
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5 Clinical implications and future perspectives 
The overall goal of this thesis work was to provide insights into efficient clinical therapies 
for HIE and IR-induced brain injury. To this end, pharmacological interventions aimed at 
the control of apoptotic and inflammatory responses after HI were studied. A previously 
unknown mechanism for the therapeutic effects of neural stem cell-based therapies was 
revealed, and the application of NPC-derived CM to promote neuroprotection after brain 
injury was proposed. In addition, we found that peripheral monocyte-derived macrophages 
do not participate in the inflammatory response in the irradiated brain, contributing to a 
better understanding of neurogenesis impairment after exposure to radiation.  
Apoptosis plays a prominent role in the immature vs. adult brain in response to HI. 
Therapeutic strategies targeting programmed cell death have been extensively studied, 
achieving promising outcomes. Here, BIP administered before HI prevented delayed cell 
death by inhibiting the activation of Bax, thus providing an additional intervention target. 
However, it is still too early to conclude that BIP can be utilized in clinical treatment 
modalities. Unlike in animal models, it is not always possible to define the onset of 
ischemia and reperfusion in humans; therefore, additional research regarding the effects of 
delayed BIP administration in rodent models might help to understand its therapeutic 
impact when given during later stages of HIE. On the other hand, we did study the effect of 
delayed Q-VD-OPh administration in mice with HI-induced brain damage. The caspase 
inhibitor decreased long-term tissue loss, but only transiently enhanced behavioral 
performance. The question remains if complete restoration could be achieved with caspase 
inhibitors. Considering that neuronal damage after HI involves multiple signaling pathways, 
combinatorial therapy for HIE is probably required to achieve the best outcome, as long as 
the cascade of damaging events and the temporal window of efficacy for the tested drugs 
are fully defined.  
Macrophages elicit inflammatory responses under neuropathological conditions through the 
production of various cytokines, growth factors, and chemokines. Functional macrophage 
heterogeneity has long been recognized in the peripheral nervous system, but until recently, 
was largely ignored in the CNS. In the injured brain, the macrophage population consists of 
both resident microglia and infiltrating monocyte-derived macrophages that perform 
distinct functions. The post-ischemic inflammatory response, comprising activation of 
resident microglia and infiltration of peripheral macrophages, contributes to ischemic brain 
injury. Anti-inflammatory and immunomodulatory strategies are neuroprotective in the 
treatment of brain damage, and both diminish microglial activation. Interestingly, caspase-8 
	  
	  
31	  
and caspase-3/-7 are reportedly mediators of microglial activation. Here, Q-VD-OPh 
diminished post-ischemic inflammation and reduced tissue loss after HI, but its direct effect 
on microglial activation was unclear. Additional exploration of the impact of caspase 
inhibitors on the modulation of the microglial phenotype and the infiltration of peripheral 
macrophages would assist in addressing this question.  
Regarding IR-induced brain injury, neuroinflammation after radiation exposure has been 
suggested to alter the microenvironment of the neurogenic niche, thereby preventing 
neuronal differentiation of precursor cells. Unlike the case of spinal cord injury, where 
monocytes are recruited to the lesion site and participate in repair, peripheral monocyte-
derived macrophages do not appear to contribute to the inflammatory response in the 
irradiated hippocampus. Instead, our findings indicate that the acute inflammatory state is 
largely mediated by resident reactive microglia, whereas chronic inflammation is mediated 
by other cells, particularly activated astrocytes. Of note, β-1,4-galactosyltransferase-6 is 
upregulated in activated astrocytes in multiple sclerosis lesions, which drives the 
transcription of neuroinflammatory-associated genes and contributes to disease 
pathogenesis. Further studies are needed to similarly unravel the functions of activated 
astrocytes and microglia in IR-provoked brain lesions.  
This thesis shows that caspase-dependent NPC death is essential for the release of 
components that mediate the resilience of neural cells. This concept differs from previous 
concepts linking the protective effects of stem cell therapy to repair mechanisms via cell 
replacement. We propose that the therapeutic application of stable, well-defined NPC-
derived CM fractions obtained under standardized conditions in vitro could achieve better 
results than cell-based therapies. The latter are hindered by various inherent obstacles, 
including variability among different cell transplant preparations, uncontrolled cell 
migration, nonfunctional cell integration into host tissue and circuitry, and tumorigenesis. 
By contrast, NPCs are relatively easy to isolate and expand, and large amounts of CM can 
be produced fairly quickly. Because the CM is highly stable at 37°C for several days, a 
continuous infusion of fresh CM or active CM constituents (e.g., prdx-1, galectin-1) is 
possible, thereby likely increasing therapeutic benefits.  
Finally, this thesis highlights apoptosis and inflammation as two crucial components of 
neuropathogenesis in HI- and IR-induced brain injuries. The determination of an optimal 
therapeutic window is of utmost concern for the development of efficacious clinical 
interventions for such conditions. If a therapeutic window cannot be identified, delayed 
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treatment focusing on the regulation of apoptosis and inflammation becomes critical for the 
management of brain damage. 
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